SteelPeak Wealth LLC Boosts Stake in UnitedHealth Group Incorporated $UNH

Key Points

• SteelPeak Wealth LLC boosted its stake in UnitedHealth by 28.9% in Q4 to 42,727 shares, worth about $14.1 million per its latest SEC filing.
• UnitedHealth slightly beat Q4 estimates with $2.11 EPS and $113.73 billion in revenue (revenue up 12.3% year‑over‑year) and recently paid a $2.21 quarterly dividend (annualized $8.84, ~3.2% yield).
• Analyst sentiment is mixed: upgrades point to Optum margin and AI upside, but execution issues and potential RADV audit exposure are key risks; consensus is a Moderate Buy with an average target of $363.38.

SteelPeak Wealth LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 28.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 42,727 shares of the healthcare conglomerate's stock after buying an additional 9,576 shares during the period. SteelPeak Wealth LLC's holdings in UnitedHealth Group were worth $14,105,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of UNH. Analyst IMS Investment Management Services Ltd. boosted its stake in shares of UnitedHealth Group by 69.8% during the fourth quarter. Analyst IMS Investment Management Services Ltd. now owns 2,523 shares of the healthcare conglomerate's stock worth $833,000 after buying an additional 1,037 shares during the period. Toth Financial Advisory Corp raised its stake in UnitedHealth Group by 3.5% during the 4th quarter. Toth Financial Advisory Corp now owns 24,519 shares of the healthcare conglomerate's stock valued at $8,094,000 after acquiring an additional 823 shares during the last quarter. Quintet Private Bank Europe S.A. lifted its position in UnitedHealth Group by 1.0% during the 4th quarter. Quintet Private Bank Europe S.A. now owns 86,033 shares of the healthcare conglomerate's stock worth $28,400,000 after acquiring an additional 836 shares during the period. Kavar Capital Partners Group LLC increased its holdings in shares of UnitedHealth Group by 39.8% in the fourth quarter. Kavar Capital Partners Group LLC now owns 2,245 shares of the healthcare conglomerate's stock valued at $741,000 after purchasing an additional 639 shares during the period. Finally, Park Edge Advisors LLC lifted its holdings in shares of UnitedHealth Group by 28.5% during the fourth quarter. Park Edge Advisors LLC now owns 1,712 shares of the healthcare conglomerate's stock worth $565,000 after purchasing an additional 380 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.0%

Shares of NYSE UNH opened at $277.30 on Friday. The firm has a market cap of $251.70 billion, a price-to-earnings ratio of 21.02, a PEG ratio of 1.28 and a beta of 0.40. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79. The stock's 50-day simple moving average is $283.03 and its 200-day simple moving average is $319.91. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts' consensus estimates of $2.09 by $0.02. The business had revenue of $113.73 billion during the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a net margin of 2.69% and a return on equity of 14.79%. The business's quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter last year, the company earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date was Monday, March 9th. UnitedHealth Group's payout ratio is 67.02%.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Raymond James upgraded UNH to Outperform and set a $330 target, citing higher earnings upside from Optum margin improvement and AI initiatives — a catalyst for near‑term buying interest. UnitedHealth Group NYSE: UNH Trading 1.2% Higher After Analyst Upgrade
• Positive Sentiment: Analysts and outlets are highlighting UNH’s planned multibillion‑dollar AI spend (including the Avery generative AI platform) as a lever to speed claims processing and lower costs — a medium‑term margin story if execution succeeds. How UnitedHealth’s AI Bet And Optum Margin Push At UnitedHealth Group (UNH) Has Changed Its Investment Story
• Neutral Sentiment: Coverage pointing to a “quiet turnaround” and pieces framing UNH as a recovery/opportunity trade reflect growing investor interest but hinge on sustained margin progress and regulatory outcome. These narratives support demand but don’t remove execution risk. The Quiet Turnaround In UnitedHealth
• Neutral Sentiment: Analyses benchmarking Q4 and longer‑term valuation debates highlight that UNH’s recent share decline has attracted some buy‑the‑dip interest from bullish analysts, balancing skepticism over near‑term volatility. Health Insurance Providers Stocks Q4 Recap: Benchmarking UnitedHealth NYSE: UNH
• Negative Sentiment: Mairs & Power flagged that UnitedHealth’s own operational issues in 2025 were a material drag — a reminder that execution lapses (claims, workflows) can erase expected benefits from tech investments and weigh near‑term results. Self-Inflicted Operational Issues Pressured UnitedHealth Group (UNH) In 2025
• Negative Sentiment: Leerink warns of sizable RADV (risk‑adjustment) audit exposure — a regulatory/financial risk that could lead to Medicare Advantage revenue adjustments and earnings pressure if assessments materialize. This is a key downside risk for investors to monitor. Leerink sees UnitedHealth stock facing largest RADV audit exposure

Wall Street Analyst Weigh In

Several research analysts recently issued reports on UNH shares. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $408.00 to $361.00 and set an "outperform" rating for the company in a report on Wednesday, January 28th. Barclays cut their price target on UnitedHealth Group from $391.00 to $327.00 and set an "overweight" rating for the company in a research note on Friday, January 30th. Oppenheimer lowered their target price on UnitedHealth Group from $415.00 to $385.00 and set an "outperform" rating on the stock in a report on Wednesday, January 28th. JPMorgan Chase & Co. lowered their price target on shares of UnitedHealth Group from $425.00 to $389.00 and set an "overweight" rating for the company in a report on Monday, February 2nd. Finally, Jefferies Financial Group dropped their target price on UnitedHealth Group from $418.00 to $340.00 and set a "buy" rating for the company in a research note on Wednesday, January 28th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, seven have assigned a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $363.38.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.